N von Bubnoff Selected Research

N von Bubnoff Research Topics

4	Neoplasms (Cancer) 08/2015 - 05/2001
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2013 - 05/2003
4	Blast Crisis (Blast Phase) 03/2013 - 02/2005
3	Leukemia 10/2005 - 03/2000
2	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2017 - 10/2015
1	Cytopenia 10/2015
1	Disease Progression 04/2006
1	Systemic Mastocytosis 09/2005
1	Eosinophilia 02/2005
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2003
1	Philadelphia Chromosome 05/2003
1	Hodgkin Disease (Hodgkin's Disease) 05/2001
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2000
1	Thrombocytopenic Purpura (Thrombopenic Purpura) 02/2000

6	Imatinib Mesylate (Gleevec)FDA Link 03/2013 - 05/2003
4	Phosphotransferases (Kinase)IBA 02/2011 - 03/2000
2	nilotinib FDA Link 07/2007 - 09/2005
2	Tyrosine Kinase InhibitorsIBA 07/2007 - 09/2005
1	ruxolitinibIBA 10/2015
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2015
1	S-Phase Kinase-Associated Proteins (Skp1 Protein)IBA 08/2015
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 08/2015
1	Dasatinib (BMS 354825)FDA Link 03/2013
1	NucleotidesIBA 03/2013
1	Pharmaceutical PreparationsIBA 02/2011
1	Sunitinib (Sutent)FDA Link 08/2010
1	Sorafenib (BAY 43-9006)FDA Link 08/2010
1	TOR Serine-Threonine KinasesIBA 10/2005
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2005
1	Proteins (Proteins, Gene)FDA Link 05/2003
1	Oncogene Proteins (Oncogene Protein)IBA 05/2003
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 05/2001
1	Glucose (Dextrose)FDA LinkGeneric 05/2001
1	Tyrosine (L-Tyrosine)FDA Link 03/2000
1	Interferon-alpha (Interferon Alfa)IBA 03/2000